NCODA leaders are looking forward to presenting at Asembia tomorrow, May 1st at 2pm PDT. In addition to the presentation, we hope to meet many of you at our booth (#1217) in the exhibit hall!
ncoda.org/driving-qualit…

This week on The PQI Podcast, we honor #ColorectalCancer awareness month with guest Dr. Robert Zaiden from Baptist MD Anderson to discuss ctDNA testing in GI cancers and his teams impact on patient care. Stream now: ncoda.org/pqi-podcast/

NCODA Executive Council Member Lucio N. Gordan of Florida Cancer Specialists & Research Institute shares insight and thoughts on the ongoing Change #Healthcare issue and the importance of keeping patient care at the forefront bit.ly/4chEUXq

NCODA applauds the efforts of Representative Carter, Barragán, Miller-Meeks, and DeGette.
buddycarter.house.gov/news/documents…

NCODA's Sadid, PharmD, and PAN Foundation's Niles, MBA, discuss #AlternativeFundingPrograms in Pharmacy Times Oncology, highlighting challenges in high-cost formularies, shedding light on medication exclusions affecting patient options.
bit.ly/3GJhewh
#PatientAdvocacy

Member registration is OPEN for the 2024 NCODA International Spring Forum in Dallas, TX on April 3rd-5th!

NCODA members, secure your spot now: ncoda.org/spring-forum/
#oncology #CancerCare

We are thrilled to announce the newest addition to the NCODA leadership team, Patrick (Pat) Connelly. Pat joins us as Chief Development and Strategy Officer.

Please join us in extending a warm welcome!

Join NCODA and clinical leaders from across the country for a Virtual 'Stark Law' Town Hall taking place this Thursday, August 24th at 5:30pm ET. All members of the oncology ecosystem are invited to join! Learn more: ncoda.org/ncoda-stark-la…

Attention #myeloma clinicians, check out this NCODA PQI on how to incorporate MRD testing into your practice. Learn more at adaptivebio.tech/35y #mmsm #mmMRD clonoSEQ is FDA-cleared to assess MRD in CLL, MM and B-ALL. For further info: rb.gy/8tju9y

📢 NCODA is committed to improving #pharmacy practice and enhancing #oncology patient care through engagement, collaboration, and education. Today, our team presented on the NCODA MIP #Accreditation at Asembia's AXS23 Summit in Las Vegas. ncoda.org/accreditation/

With an upcoming policy expiration, NCODA is calling for the Centers for Medicare & Medicaid Services to immediately retract a portion of an FAQ that suggests that physician practices mailing medications would be in violation of the Stark Law. bit.ly/41IYaY8

We are excited to share the Spring 2023 Issue of Inspire will be released this month! Stay tuned for the official release date, and in the meantime, you can find the first issue at the link below!
ncoda.org/inspire/#1

Three leading medically integrated oncology practices were awarded NCODA’s Center of Excellence Medically Integrated Pharmacy Accreditation at the NCODA International Spring Forum that took place last week in Indianapolis, IN. ncoda.org/three-leading-…

NCODA is proud to announce the formation of its International Executive Council (IEC). The IEC will provide insight and leadership to NCODA regarding meeting the ever-changing needs of #oncology patients and #healthcare professionals around the world. ncoda.org/ncoda-internat…

NCODA is delighted to announce the expansion of its Executive Council with the appointment of three appointed oncology healthcare leaders. The new council members were selected for their demonstrated leadership in the oncology landscape.
ncoda.org/ncoda-appoints…

Last week, International NCODA Member - George P. Patrinos - was published in The Lancet featuring results of a 12-gene pharmacogenetics panel to prevent adverse drug reactions.

sciencedirect.com/science/articl…

NCODA is pleased to announce two new Center of Excellence (CoE) Medically Integrated Pharmacy (MIP) accreditation offerings: 1) Multi-specialty and 2) Multi-specialty with #Oncology Focus.
ncoda.org/ncoda-launches…

NCODA is excited to announce the creation of a new and innovative Accredited Medically-Integrated #Oncology Pharmacy (MIOP) Residency Program.
ncoda.org/new-accredited…

NCODA is proud of the Legislative & Policy Advisory Committee (LPAC) for maintaining their steadfast goal to educate our membership and shed light on the world of #oncology - related legislation.

Read the 2022 LPAC recap and statement at the link below.
bit.ly/3hDeCXT

To empower the medically-integrated oncology team and ensure an advanced level of patient care, NCODA’s Oncology Pharmacy Technician Association (OPTA) has a new certification program to advance the knowledge and understanding of oncology pharmacy care. bit.ly/3hcTRSO